We’re reshaping the future of respiratory care with simple and accurate technology that can be used by
physicians and patients. Our technology has been validated in peer-reviewed studies.
At least four times a year we release updates of our solution taking into account the feedback we regularly collect from variety of sources and mechanisms including workshops, surveys and directly from users. At NuvoAir we welcome any opportunity to learn how our technology can be developed to continue to improve the lives of people living with long term conditions, their caregivers and clinical teams.
Real-World-Data from our cystic fibrosis engagements reveals great health economic outcome potential and staggering acceptance
understanding of CF
ePS1.07 Patient experience of virtual consultations: survey results, Journal of Cystic Fibrosis Volume 19, Supplement 2, June 2020, Page s39
Acceptance of NuvoAir solution on a scale from 0-10